EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Obesity and Clinical Characteristics of Inflammatory Bowel Disease

Livia Biancone, Roberto Mancone, Livia Biancone, Sara Concetta Schiavone, Mariasofia Fiorillo, Chiara Menna, Stefano Migliozzi, Benedetto Neri

Obesity Facts · 2025

DOI: 10.1159/000545436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity Facts, 2025. Verfasst von Livia Biancone und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Medicine, Gastroenterology Unit, University "Tor Vergata" of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Body Mass Index, Obesity, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The frequency of obesity and possible correlations with characteristics and outcome of inflammatory bowel disease (IBD) are undefined. Primary aim was to assess the body mass index (BMI) distribution in IBD patients in follow-up. Secondary aim was to compare clinical characteristics and course of IBD in normal weight versus overweight or obese patients.

Methods

Adult IBD patients in regular follow-up were prospectively enrolled and BMI was recorded during outpatient visits. Comparisons were assessed by the Student t-test, Mann-Whitney U test and Chi-square test, as appropriate.

Results

In the 300 IBD patients enrolled (150 Crohn’s disease [CD], 150 ulcerative colitis [UC]), BMI distribution included: 16 (5.3%) underweight, 170 (56.7%) normal weight, 92 (30.7%) overweight, 22 (7.3%) obese patients. For the secondary aim, the 16 underweight patients were excluded, thus leaving 284 patients for the analysis (141 [49.6%] CD; 143 [50.4%] UC). Among these, 114 (40.2%) were overweight/obese and 170 (59.8%) normal weight. CD group included 89 (63.1%) normal weight and 52 (36.9%) overweight/obese patients. Perianal disease and refractoriness to biologics were more frequent in overweight/obese than normal weight CD patients (9 [10.1%] vs. 12 [23%], p = 0.03; 0 [0%] vs. 4 [23.4%], p = 0.01). In UC group, there were 81 (56.6%) normal weight and 62 (63.4%) overweight or obese patients.

Conclusion

In IBD patients in follow-up, the proportion of underweight patients is low. Overweight and obese CD patients showed a higher frequency of perianal disease and refractoriness to biologics. BMI may influence phenotype and responsiveness to biologics in CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body Mass IndexObesityColitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesHumansFemaleMaleAdultMiddle AgedProspective StudiesOverweightThinnessFollow-Up StudiesYoung Adult

Stichwörter der Autor:innen

BiologicsClinical characteristicsInflammatory bowel diseaseObesityOverweight

Autor:innen und Institutionen

  • Department of Systems Medicine, Gastroenterology Unit, University "Tor Vergata" of Rome, Rome, Italy.
  • Department of Systems Medicine, Gastroenterology Unit, University "Tor Vergata" of Rome, Rome, Italy, roberto.mancone@yahoo.it.

Zitieren

APA

Biancone, L., Mancone, R., Biancone, L., Schiavone, S. C., Fiorillo, M., Menna, C., Migliozzi, S., & Neri, B. (2025). Obesity and Clinical Characteristics of Inflammatory Bowel Disease. Obesity Facts. https://doi.org/10.1159/000545436

Vancouver

Biancone L, Mancone R, Biancone L, Schiavone SC, Fiorillo M, Menna C, et al. Obesity and Clinical Characteristics of Inflammatory Bowel Disease. Obesity Facts. 2025. doi:10.1159/000545436

BibTeX
@article{Biancone2025,
  author = {Biancone, Livia and Mancone, Roberto and Biancone, Livia and Schiavone, Sara Concetta and Fiorillo, Mariasofia and Menna, Chiara and Migliozzi, Stefano and Neri, Benedetto},
  title = {Obesity and Clinical Characteristics of Inflammatory Bowel Disease},
  journal = {Obesity Facts},
  year = {2025},
  doi = {10.1159/000545436}
}
Kostenlos starten →